PROPANC BIOPHARMA, INC. Capital Expenditures
PROPANC BIOPHARMA, INC. (PPCB) reported Capital Expenditures of $4.91 thousand for the 9-month period ending 2026-03-31, per its S-1 filed 2026-07-17.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-07-17
- PROPANC BIOPHARMA, INC. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $154.00.
- PROPANC BIOPHARMA, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $2.27K.
- PROPANC BIOPHARMA, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $2.49K.
- PROPANC BIOPHARMA, INC. payments to acquire property, plant, and equipment for the quarter ending 2019-06-30 was $0.00.
- PROPANC BIOPHARMA, INC. payments to acquire property, plant, and equipment for fiscal 2019 was $2.87K.
- PROPANC BIOPHARMA, INC. payments to acquire property, plant, and equipment for fiscal 2016 was $9.88K, a 153.24% increase from fiscal 2015.
- PROPANC BIOPHARMA, INC. payments to acquire property, plant, and equipment for fiscal 2015 was $3.90K.
- PROPANC BIOPHARMA, INC. payments to acquire property, plant, and equipment for fiscal 2014 was $0.00.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month | Payments to Acquire Property, Plant, and Equipment 51 month | Payments to Acquire Property, Plant, and Equipment 54 month | Payments to Acquire Property, Plant, and Equipment 57 month | Payments to Acquire Property, Plant, and Equipment 60 month | Payments to Acquire Property, Plant, and Equipment 63 month | Payments to Acquire Property, Plant, and Equipment 66 month | Payments to Acquire Property, Plant, and Equipment 68 month | Payments to Acquire Property, Plant, and Equipment 72 month | Payments to Acquire Property, Plant, and Equipment 75 month | Payments to Acquire Property, Plant, and Equipment 77 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | $154.00 derived: S-1 9 month − S-1 6 month · filed 2026-07-17 | $2.42K derived: sum of 2 quarters · filed 2026-07-17 | $4.91K S-1 · filed 2026-07-17 | |||||||||||
| 2025-12-31 | $2.27K derived: S-1 6 month − 10-Q 3 month · filed 2026-04-10 | $4.76K S-1 · filed 2026-04-10 | ||||||||||||
| 2025-09-30 | $2.49K 10-Q · filed 2025-11-14 | |||||||||||||
| 2019-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-10-01 | $1.21K derived: sum of 2 quarters · filed 2020-10-01 | $2.87K 10-K · filed 2020-10-01 | |||||||||||
| 2019-03-31 | $1.21K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-15 | $2.87K 10-Q · filed 2020-05-15 | ||||||||||||
| 2018-12-31 | $1.66K 10-Q · filed 2019-02-14 | |||||||||||||
| 2016-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-14 | $0.00 10-Q · filed 2017-02-14 | $9.20K derived: sum of 3 quarters · filed 2017-09-28 | $9.20K derived: sum of 4 quarters · filed 2017-09-28 | ||||||||||
| 2016-09-30 | $0.00 10-Q · filed 2016-11-10 | $9.20K derived: sum of 2 quarters · filed 2017-09-28 | $9.20K derived: sum of 3 quarters · filed 2017-09-28 | $9.20K derived: sum of 4 quarters · filed 2017-09-28 | ||||||||||
| 2016-06-30 | $9.20K derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-28 | $9.20K derived: sum of 2 quarters · filed 2017-09-28 | $9.20K derived: sum of 3 quarters · filed 2017-09-28 | $9.88K 10-K · filed 2017-09-28 | ||||||||||
| 2016-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-08 | -$3.00 derived: sum of 2 quarters · filed 2017-05-08 | $676.00 10-Q · filed 2017-05-08 | $3.66K derived: sum of 4 quarters · filed 2017-05-08 | ||||||||||
| 2015-12-31 | -$3.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-14 | $676.00 10-Q · filed 2017-02-14 | $3.66K derived: sum of 3 quarters · filed 2017-02-14 | $4.58K derived: sum of 4 quarters · filed 2017-02-14 | ||||||||||
| 2015-09-30 | $679.00 10-Q · filed 2016-11-10 | $3.66K derived: sum of 2 quarters · filed 2016-11-10 | $4.58K derived: sum of 3 quarters · filed 2016-11-10 | $4.58K derived: sum of 4 quarters · filed 2016-11-10 | ||||||||||
| 2015-06-30 | $2.98K derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-28 | $3.90K derived: sum of 2 quarters · filed 2016-09-28 | $3.90K derived: sum of 3 quarters · filed 2016-09-28 | $3.90K 10-K · filed 2016-09-28 | ||||||||||
| 2015-03-31 | $918.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-16 | $918.00 derived: sum of 2 quarters · filed 2016-05-16 | $918.00 10-Q · filed 2016-05-16 | $918.00 derived: sum of 4 quarters · filed 2016-05-16 | ||||||||||
| 2014-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-16 | $0.00 10-Q · filed 2016-02-16 | $0.00 derived: sum of 3 quarters · filed 2016-02-16 | $0.00 derived: sum of 4 quarters · filed 2016-02-16 | ||||||||||
| 2014-09-30 | $0.00 10-Q · filed 2015-11-16 | $0.00 derived: sum of 2 quarters · filed 2015-11-16 | $0.00 derived: sum of 3 quarters · filed 2015-11-16 | $0.00 derived: sum of 4 quarters · filed 2015-11-16 | ||||||||||
| 2014-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-30 | $0.00 derived: sum of 2 quarters · filed 2015-09-30 | $0.00 derived: sum of 3 quarters · filed 2015-09-30 | $0.00 10-K · filed 2015-09-30 | ||||||||||
| 2014-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-15 | $0.00 derived: sum of 2 quarters · filed 2015-05-15 | $0.00 10-Q · filed 2015-05-15 | $14.79K 10-Q · filed 2014-05-20 | ||||||||||
| 2013-12-31 | $0.00 derived: 10-Q 75 month − 10-Q 72 month · filed 2014-02-14 | $0.00 10-Q · filed 2015-02-17 | $14.79K 10-Q · filed 2014-02-14 | |||||||||||
| 2013-09-30 | $14.79K 10-Q · filed 2013-11-14 | |||||||||||||
| 2013-06-30 | $14.79K 10-K · filed 2013-10-15 | |||||||||||||
| 2013-03-31 | $0.00 derived: 10-Q 66 month − 10-Q 63 month · filed 2013-05-20 | $0.00 derived: sum of 2 quarters · filed 2013-05-20 | $0.00 derived: sum of 3 quarters · filed 2013-05-20 | $0.00 derived: sum of 4 quarters · filed 2013-05-20 | $14.79K 10-Q · filed 2013-05-20 | |||||||||
| 2012-12-31 | $0.00 derived: 10-Q 63 month − 10-Q 60 month · filed 2013-02-20 | $0.00 derived: sum of 2 quarters · filed 2013-02-20 | $0.00 derived: sum of 3 quarters · filed 2013-02-20 | $0.00 derived: sum of 4 quarters · filed 2013-02-20 | $14.79K 10-Q · filed 2013-02-20 | |||||||||
| 2012-09-30 | $0.00 derived: 10-Q 60 month − 10-K 57 month · filed 2012-11-19 | $0.00 derived: sum of 2 quarters · filed 2012-11-19 | $0.00 derived: sum of 3 quarters · filed 2012-11-19 | $14.79K 10-Q · filed 2012-11-19 | ||||||||||
| 2012-06-30 | $0.00 derived: 10-K 57 month − 10-Q 54 month · filed 2012-10-15 | $0.00 derived: sum of 2 quarters · filed 2012-10-15 | $14.79K 10-K · filed 2012-10-15 | |||||||||||
| 2012-03-31 | $0.00 derived: 10-Q 54 month − 10-Q/A 51 month · filed 2012-05-21 | $14.79K 10-Q · filed 2012-05-21 | ||||||||||||
| 2011-12-31 | $0.00 10-Q/A · filed 2012-03-07 | $14.79K 10-Q/A · filed 2012-03-07 | ||||||||||||
| 2011-06-30 | $85.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-10-15 | $157.00 derived: sum of 2 quarters · filed 2012-10-15 | $3.51K 10-K · filed 2012-10-15 | |||||||||||
| 2011-03-31 | $72.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-05-21 | $3.42K 10-Q · filed 2012-05-21 | ||||||||||||
| 2010-12-31 | $3.35K 10-Q/A · filed 2012-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |